YEM Search

搜索结果

PHF8

靶点ID:TCMBANKGE010982

靶点别名:JHDM1F; KDM7B; MRXSSD; ZNF422

靶点描述:PHD finger protein 8

染色体:X

染色体位置:Xp11.22

靶点类型:protein-coding

HERB_ID:-

HGNC_Link:20672

OMIM_Link:300560

Ensembl_Link:ENSG00000172943

靶点对应的植物

ID	拉丁名	药名	药用植物名	功能与主治	来源	药用部位	使用民族

靶点对应的化合物

化合物ID	化合物名	别名	分子式	分子质量	Smiles

TCMBANKIN002276	aminozide	B 995; SBB057747; 6853-EP2295550A2; 26949-EP2305658A1; 6853-EP2305260A1; Succinic acid-2,2-dimethylhydrazide; LS-908; 3-[N-(dimethylamino)carbamoyl]propanoic acid; Butanedioic acid mono(2,2-dimethylhydrazide); Aminozid; N-Dimethylamino-succinamidsaeure; SCHEMBL50347; diaminozide; SUCCINIC ACID, 2,2-DIMETHYLHYDRAZIDE; Daminozide [ANSI:BSI:ISO]; AK310838; 1-(2,2-Dimethylhydrazide)butanedioic acid; N-Dimethylamino-beta-carbamylpropionic acid; N-dimethylamino-beta-carbamyl propionic acid; D4015; NCGC00091281-03; B-Nine; Alar 85; 74913-15-8; MFCD00002787; 6853-EP2275425A1; 6853-EP2301934A1; MolPort-002-927-289; EINECS 216-485-9; NCGC00091281-04; 3-(N',N'-dimethylhydrazinecarbonyl)propanoic acid; K-5005; W-107985; 6853-EP2371808A1; AC1L25O2; 4-(2,2-Dimethylhydrazino)-4-oxobutanoic acid; N-dimethylamino-beta-car bamyl propionic acid; AI3-50727; Succinic 1,1-dimethyl hydrazide; FT-0629276; D0B2WZ; Succinic acid, mono(2,2-dimethylhydrazide); EPA Pesticide Chemical Code 035101; NCGC00259748-01; AN-49511; MCULE-6532969482; AKOS005208038; DMASA; Kylar; NINE; 6853-EP2298760A1; Dazide; N-Dimethylamino-succinamidsaeure [German]; NCGC00091281-01; DSSTox_CID_370; CCG-55990; DYaK; NCGC00254822-01; Daminozide (B9); alar-85; NCI-C03827; 6853-EP2275420A1; 6853-EP2308882A1; 6853-EP2272516A2; Dimethylaminosuccinamic acid; CHEMBL2164243; 6853-EP2308875A1; micro yen(2,2- paragraph signthorn(1/4)x>>uo poundeA) paragraph sign inverted exclamation mark paragraph signthornEao poundeA; 6853-EP2305686A1; SMR000777919; 1596-84-5; Succinic Acid, N,N-dimethylhydrazide; AB0018582; NCGC00091281-05; 26949-EP2314583A1; DAMINOZIDE (DIMETHYLAMINOSUCCINAMIC ACID); DSSTox_RID_75546; NCGC00091281-07; 6853-EP2292613A1; C10996; Daminozide, PESTANAL(R), analytical standard; 6853-EP2292612A2; 4-(2,2-dimethylhydrazinyl)-4-oxobutanoic acid; CCRIS 191; ST50308567; Jsp003172; HY-13643; 6853-EP2274983A1; Succinic N',N'-dimethylhydrazide; Succinic acid N,N-dimethylhydrazide; CHEBI:4312; SR-01000644985-1; Succinic acid 2,2-dimethylhydrazide; Bernsteinsaeure-2,2-dimethylhydrazid [German]; ALAR; 6853-EP2289892A1; 4-(2,2-Dimethylhydrazino)-4-oxobutanoic acid #; Butanedioic acid, mono(2,2-dimethylhydrazide); BDBM50395076; DTXSID9020370; NOQGZXFMHARMLW-UHFFFAOYSA-N; Succinic acid, mono-2,2-dimethylhydrazine; Dimas; 6853-EP2316836A1; Caswell No. 808; BRN 1863230; ZINC1532111; Tox21_202199; CS-1288; 4-(2,2-dimethylhydrazino)-4-oxo-butanoic acid; NCGC00091281-02; F6KF33M5UB; HSDB 1769; Aminozide; N-(Dimethylamino)succinamic acid; CAS-1596-84-5; UNII-F6KF33M5UB; Succinic acid mono-(2,2-dimethylhydrazide); SADH; Succinic acid mono(2,2-dimethylhydrazide); 6853-EP2292615A1; 6853-EP2308865A1; Daminozide; MLS006012018; S346; 2,2-Dimethylhydrazid kyseliny jantarove [Czech]; 26949-EP2371823A1; Bernsteinsaeure-2,2-dimethylhydrazid; 6853-EP2277879A1; 1861-26-3; DSSTox_GSID_20370; 2,2-Dimethylhydrazid kyseliny jantarove; Tox21_300919; GTPL7025	C6H12N2O3	160.17 g/mol	CN(C)NC(=O)CCC(=O)O
TCMBANKIN043561	Laminine	AC1L98PS; FT-0695852; delta-trimethyllysine; N-EPSILON,N-EPSILON,N-EPSILON-TRIMETHYLLYSINE; S)-5-amino-5-carboxy-N,N,N-trimethyl-1-pentanaminium; 23284-33-5; Trimethyllysine; (S)-2-amino-6-(trimethylammonio)hexanoic acid; C-53472; C03793; AKOS006272412; N6,N6,N6-Trimethyl-L-lysine; N(6),N(6),N(6)-trimethyl-L-lysine; (S)-2-amino-6-(trimethylammonio)hexanoate; (2S)-2-amino-6-(trimethylazaniumyl)hexanoate		189.28 g/mol
TCMBANKIN057905	ferrum	iron	Fe	55.84 g/mol	[Fe]
TCMBANKIN057947	glucoside	SCHEMBL25601; FT-0626726; 136760-05-9; .beta.-D-Glucose; UNII-J4R00M814D; beta-glucose; 207381-EP2280021A1; 133947-06-5; beta-delta-Glucopyranose; MCULE-4260589665; CHEBI:15903; beta-d-(+)-glucose; BDBM50240803; 28905-12-6; MolPort-006-111-449; KB-277820; DB02379; D07ONX; 6-(hydroxymethyl)tetrahydro-2H-pyran-2,3,4,5-tetrol; SC-25121; NSC759603; (1->6)-beta-D-glucopyranan; 1,2-beta-D-Glucan; EINECS 207-756-2; beta-D-Glc; (1,2-beta-D-glucosyl)n; (2R,3R,4S,5S,6R)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol; .beta.-D-Glucopyranose; FT-0622903; NSC-759603; Beta-D-glucose anhydrous; b-D-Glucopyranose; CHEMBL1614854; beta-D-glucopyranose; W-202206; 1,5]; AC1L21QQ; C00221; Grape sugar; BG01505598; Galactitol,1,5-anhydro-1-C-phenyl-; G0047; 53991-51-8; 492-61-5; b-d-glucose; 9001-37-0; BGC; WQZGKKKJIJFFOK-VFUOTHLCSA-N; (1->3)-beta-D-glucan; CTK8F0914; AKOS016010209; DB-051616; AE-562/43459286; 207381-EP2280004A1; 50986-29-3; AK306225; (1->3)-beta-D-glucopyranan; TR-038298; beta-(1,3)-glucan; Curdlan; b-Glucose; .beta.-d-Glucose, anhydrous; ZINC3833800; CHEBI:27517; CHEBI:37671; FCH1120200; beta-Dextrose; (1->4)-beta-D-glucopyranan; (1->6)-beta-D-glucan; WURCS=1.0/1,0/[12122h; beta-D-glucose; (2R,3R,4S,5R,6R)-6-(Hydroxymethyl)tetrahydro-2H-pyran-2,3,4,5-tetraol; (1->2)-beta-D-glucopyranan; Pharmakon1600-01300015; ZYMOSAN; AJ-45802; (+)-Glucose; CHEBI:18246; 207381-EP2280020A1; (1->2)-beta-D-glucan; b-Dextrose; 108942-17-2; (2R,3R,4S,5S,6R)-6-(Hydroxymethyl)tetrahydro-2H-pyran-2,3,4,5-tetraol; MFCD00063989; 492-64-8; CHEBI:27380; (1->4)-beta-D-glucan; anhydrous glucose; Glucose, (beta-D)-Isomer; J4R00M814D; Callose; beta-D-Glucopyranose, anhydrous; Beta-d-glucose, anhydrous; 128009-02-9; AX8115243;BGC	C6H12O6	180.16 g/mol	C(C1C(C(C(C(O1)O)O)O)O)O

靶点对应的疾病

疾病ID	疾病名	MeSH名	HPO名	UMLS名	疾病类型

TCMBANKDI000076		Neoplasms	-	Neoplastic Process	group
TCMBANKDI000166		-	-	Neoplastic Process	disease
TCMBANKDI002294		-	Abnormality of head or neck	Finding	phenotype
TCMBANKDI003353		Pathological Conditions, Signs and Symptoms; Neoplasms	-	Neoplastic Process	phenotype
TCMBANKDI003879		Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Male Urogenital Diseases; Endocrine System Diseases	Abnormality of the genitourinary system	Congenital Abnormality	disease
TCMBANKDI004145		Mental Disorders	Abnormality of the nervous system	Mental or Behavioral Dysfunction	group
TCMBANKDI008874		-	Abnormality of head or neck	Finding	phenotype
TCMBANKDI009827		Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Musculoskeletal Diseases; Respiratory Tract Diseases; Stomatognathic Diseases; Otorhinolaryngologic Diseases	Abnormality of head or neck	Congenital Abnormality	disease
TCMBANKDI010081		Musculoskeletal Diseases	Abnormality of the skeletal system	Finding	phenotype
TCMBANKDI013615		Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Musculoskeletal Diseases	Abnormality of limbs; Abnormality of the skeletal system	Congenital Abnormality	disease
TCMBANKDI017024		Neoplasms; Respiratory Tract Diseases	-	Neoplastic Process	disease
TCMBANKDI019972		-	Abnormality of head or neck	Finding	phenotype
TCMBANKDI021353		-	Abnormality of head or neck	Anatomical Abnormality	phenotype
TCMBANKDI023751		Pathological Conditions, Signs and Symptoms; Nervous System Diseases	Abnormality of the musculature	Finding	phenotype
TCMBANKDI024535		Neoplasms; Respiratory Tract Diseases	Neoplasm; Abnormality of the respiratory system	Neoplastic Process	disease
TCMBANKDI025420		Digestive System Diseases; Neoplasms	Abnormality of the digestive system; Neoplasm	Neoplastic Process	disease
TCMBANKDI029054		Mental Disorders	-	Mental or Behavioral Dysfunction	group
TCMBANKDI031192		Neoplasms; Male Urogenital Diseases	-	Neoplastic Process	disease
TCMBANKDI032209		-	Abnormality of head or neck	Finding	phenotype